Mutations in the PALB2 gene, which is a partner and localizer of BRCA2, have been demonstrated to increase the risk of PC as they have been recorded in up to 3% of patients with familial PC [25,26,27,28]. This evidence concerns the gene PALB2 and pachyonychia congenita.